Literature DB >> 27940165

Study of the pH-sensitive mechanism of tumor-targeting liposomes.

Yang Fan1, Cong Chen1, Yiheng Huang1, Fang Zhang1, Guimei Lin2.   

Abstract

Currently, the phosphatidylethanolamine-based, pH-sensitive, liposome drug-delivery system has been widely developed for efficient, targeted cancer therapy. However, the mechanism of pH sensitivity was unclear; it is a main obstacle in controlling the preparation of pH-sensitive liposomes (PSLs).Therefore, our research is aimed at clarifying the pH-response mechanism of the various molecules that compose liposomes. We chose the small pH-sensitive molecules oleic acid (OA), linoleic acid (LA) and cholesteryl hemisuccinate (CHEMS) and the fundamental lipids cholesterol and phosphatidylethanolamine (PE) as test molecules. The PSLs were prepared using the thin-film hydration method and characterized in detail at various pH values (pH 5.0, 6.0 and 7.4), including particle size, ζ-potential, drug encapsulation efficiency and drug loading. The surface structure was observed by transmission electron microscopy (TEM), and the electrical conductivity of the liposome dispersion was also tested. The calorimetric analysis was conducted by Nano-differential scanning calorimetry (Nano-DSC). The in vitro drug release profile showed that PSLs exhibit good pH sensitivity. At neutral pH, the particle size was approximately 150nm, and it dramatically increased at pH 5.0. The ζ-potential increased as the pH decreased. The Nano-DSC results showed that cholesterol and CHEMS can both increase the stability and phase transfer temperature of PSLs. Conductivity increased to a maximum at pH 5.0 and was rather low at pH 7.4. In conclusion, results show that the three kinds of liposomes have pH responsive release characteristics in acidic pH. The OA-PSLs have a pH sensitive point of 5. Since CHEMS has a cholesterol-like structure, it can stabilizes the phospholipid bilayer under neutral conditions as shown in the Nano-DSC data, and because it has a special steroidal rigid structure, it exhibits better pH response characteristics under acidic conditions.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug delivery; Nano-DSC; Phase transition; Tumor mileu response; pH-sensitive liposome

Mesh:

Substances:

Year:  2016        PMID: 27940165     DOI: 10.1016/j.colsurfb.2016.11.042

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  19 in total

1.  Membrane Loaded Copper Oleate PEGylated Liposome Combined with Disulfiram for Improving Synergistic Antitumor Effect In Vivo.

Authors:  Lingli Zhou; Liu Yang; Chulei Yang; Yi Liu; Qiuyue Chen; Wenli Pan; Qing Cai; Lifeng Luo; Lu Liu; Shan Jiang; Haibing He; Yu Zhang; Tian Yin; Xing Tang
Journal:  Pharm Res       Date:  2018-05-23       Impact factor: 4.200

Review 2.  Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting.

Authors:  Muhammad Abdur Rahim; Nasrullah Jan; Safiullah Khan; Hassan Shah; Asadullah Madni; Arshad Khan; Abdul Jabar; Shahzeb Khan; Abdelbary Elhissi; Zahid Hussain; Heather C Aziz; Muhammad Sohail; Mirazam Khan; Hnin Ei Thu
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

3.  A multi-hit therapeutic nanoplatform for hepatocellular carcinoma: Dual stimuli-responsive drug release, dual-modal imaging, and in situ oxygen supply to enhance synergistic therapy.

Authors:  Taiying Chen; Ngalei Tam; Yu Mao; Chengjun Sun; Zekang Wang; Yuchen Hou; Wuzheng Xia; Jia Yu; Linwei Wu
Journal:  Mater Today Bio       Date:  2022-06-23

4.  A pH-sensitive liposome formulation of a peptidomimetic-Dox conjugate for targeting HER2 + cancer.

Authors:  Jafrin Jobayer Sonju; Achyut Dahal; Sitanshu S Singh; Xin Gu; William D Johnson; Chandra Mohan Reddy Muthumula; Sharon A Meyer; Seetharama D Jois
Journal:  Int J Pharm       Date:  2021-12-09       Impact factor: 6.510

Review 5.  RNA interference-based therapy and its delivery systems.

Authors:  Xiuhui Chen; Lingegowda S Mangala; Cristian Rodriguez-Aguayo; Xianchao Kong; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

Review 6.  Electrospun Nanofibers for Cancer Therapy.

Authors:  Huanhuan Luo; Tianyang Jie; Li Zheng; Chenglong Huang; Gang Chen; Wenguo Cui
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  A Promising Biocompatible Platform: Lipid-Based and Bio-Inspired Smart Drug Delivery Systems for Cancer Therapy.

Authors:  Min Woo Kim; Seung-Hae Kwon; Jung Hoon Choi; Aeju Lee
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

Review 8.  Nanomedicines in the treatment of colon cancer: a focus on metallodrugs.

Authors:  Pedro Farinha; Jacinta O Pinho; Mariana Matias; M Manuela Gaspar
Journal:  Drug Deliv Transl Res       Date:  2021-02-22       Impact factor: 4.617

9.  Mechanistic Insight into How PEGylation Reduces the Efficacy of pH-Sensitive Liposomes from Molecular Dynamics Simulations.

Authors:  Mohammad Mahmoudzadeh; Aniket Magarkar; Artturi Koivuniemi; Tomasz Róg; Alex Bunker
Journal:  Mol Pharm       Date:  2021-06-06       Impact factor: 4.939

Review 10.  State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.

Authors:  Elmira Heidarli; Simin Dadashzadeh; Azadeh Haeri
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.